This inventor holds 1 USPTO granted patent. Top assignee: Eli Lilly and Company. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Pierre Yves Michellys: Innovator in PPAR Agonists
Introduction
Pierre Yves Michellys is a notable inventor based in San Diego, CA. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of novel compounds that act as modulators of PPAR receptors. His work has implications for various therapeutic applications.
Latest Patents
One of his key patents is titled "Oxazolyl-aryloxyacetic acid derivatives and their use as PPAR agonists." This patent describes innovative compounds that serve as modulators of PPAR receptors, along with their pharmaceutically acceptable salts, solvates, and hydrates. The patent also outlines processes for synthesizing these compounds and pharmaceutical compositions that incorporate them.
Career Highlights
Pierre Yves Michellys is currently employed at Eli Lilly and Company, a leading global pharmaceutical company. His work at Eli Lilly has allowed him to focus on the development of new therapeutic agents that can improve patient outcomes.
Collaborations
Throughout his career, he has collaborated with esteemed colleagues such as Robert J Ardecky and Dawn Alisa Brooks. These collaborations have further enhanced the research and development efforts in the field of pharmaceutical innovations.
Conclusion
Pierre Yves Michellys stands out as an influential inventor in the realm of PPAR agonists, contributing valuable insights and innovations to the pharmaceutical industry. His work continues to pave the way for advancements in therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile